These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15849466)

  • 1. Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria.
    Monico CG; Olson JB; Milliner DS
    Am J Nephrol; 2005; 25(2):183-8. PubMed ID: 15849466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.
    Monico CG; Rossetti S; Olson JB; Milliner DS
    Kidney Int; 2005 May; 67(5):1704-9. PubMed ID: 15840016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hyperoxaluria].
    Cochat P; Fargue S; Bacchetta J; Bertholet-Thomas A; Sabot JF; Harambat J
    Nephrol Ther; 2011 Jul; 7(4):249-59. PubMed ID: 21636340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype.
    Coulter-Mackie MB
    Am J Nephrol; 2005; 25(3):264-8. PubMed ID: 15961945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.
    Fargue S; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2013 Oct; 1832(10):1776-83. PubMed ID: 23597595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.
    Coulter-Mackie MB; Rumsby G; Applegarth DA; Toone JR
    Mol Genet Metab; 2001 Nov; 74(3):314-21. PubMed ID: 11708860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.
    Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS
    J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major allele of the alanine:glyoxylate aminotransferase gene: seven novel mutations causing primary hyperoxaluria type 1.
    Coulter-Mackie MB; Applegarth D; Toone JR; Henderson H
    Mol Genet Metab; 2004 May; 82(1):64-8. PubMed ID: 15110324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperoxaluria: genotype-phenotype correlation.
    Pirulli D; Marangella M; Amoroso A
    J Nephrol; 2003; 16(2):297-309. PubMed ID: 12768081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
    Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
    Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
    Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease.
    Watts RW
    Adv Enzyme Regul; 1992; 32():309-27. PubMed ID: 1496924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
    Danpure CJ
    J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.
    Coulter-Mackie MB; Rumsby G
    Mol Genet Metab; 2004; 83(1-2):38-46. PubMed ID: 15464418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel.
    Frishberg Y; Rinat C; Shalata A; Khatib I; Feinstein S; Becker-Cohen R; Weismann I; Wanders RJ; Rumsby G; Roels F; Mandel H
    Am J Nephrol; 2005; 25(3):269-75. PubMed ID: 15961946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.